Boardroom Alpha
Boardroom Alpha
THRM · Additional Proxy Materials (DEFA14A) · Filed April 10, 2026

Gentherm Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 10, 2026
Ticker
THRM
Accession
0001140361-26-014268
Boardroom Alpha · Filing insights

Gentherm clarifies abstention effects on Proposal 4. Abstentions are not votes; the amendment increases the plan by 1,700,000 shares.

About Gentherm Inc
Market cap
$1.1B
1Y TSR
+15.6%
3Y TSR
−17.6%
Board grade
C-
Sector
Consumer Cyclical
CEO
William T Presley
Last annual meeting: May 14, 2026 · View full Gentherm Inc profile →
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.   )

Filed by the Registrant ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12

Gentherm Incorporated
(Name of registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):
No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11




 




PROXY SUPPLEMENT

Gentherm Incorporated (the “Company”) is providing this supplement (the “Supplement”) to its definitive proxy statement (the “Proxy Statement”) filed on April 1, 2026 with the Securities and Exchange Commission in connection with the Company’s 2026 Annual Meeting of Shareholders to be held on May 14, 2026 at 8:30 a.m. Eastern Daylight Time, and any postponement or adjournment thereof (the “annual meeting”). Capitalized terms not defined herein have the meaning set forth in the Proxy Statement.

Except to the extent described in this Supplement, none of the items or information contained in the Proxy Statement is affected by this Supplement. This Supplement does not provide all of the information that is important to your voting decisions at the annual meeting.  We encourage you to carefully read in their entirety the Proxy Statement, this Supplement and the other proxy materials previously made available to shareholders in connection with the annual meeting, all of which contain important information.

This Supplement is being filed solely to clarify the description of the effect of abstentions on Proposal 4 (Approval of the Amendment to the Gentherm Incorporated 2023 Equity Incentive Plan) set forth in the Proxy Statement. Specifically, the fourth row in the table under the heading "WHAT VOTE IS REQUIRED TO APPROVE EACH ITEM OF BUSINESS?" on page 91 of the Proxy Statement is hereby revised in its entirety to read as follows:

     
HOW DO VOTES IMPACT APPROVAL OF PROPOSAL
PROPOSAL
REQUIRED APPROVAL
FOR
WITHHOLD / AGAINST
ABSTENTION
BROKER NON-VOTES
04
Approval of an Amendment to the 2023 Equity Plan to increase by 1,700,000 the maximum number of shares of common stock that may be issued pursuant to Awards granted under the 2023 Equity Plan
Majority of votes cast
For the proposal
Against the proposal
Not a vote cast
Not a vote cast

This Supplement does not otherwise change the voting standards included in the Proxy Statement or the proposals to be acted upon at the annual meeting.

If you have already returned your proxy or provided voting instructions, you do not need to take any action unless you wish to change or revoke your prior vote. Information on how to vote your shares, or change or revoke your prior vote, is available in the Proxy Statement.

This Supplement will also be made available to shareholders at www.proxyvote.com and under the Investors’ section of our website at ir.Gentherm.com under the tab “Financial Info” and under the heading “SEC Filings.”



From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Gentherm Inc (THRM)

Reference

Frequently asked questions

When did Gentherm Inc file this DEFA14A?
Gentherm Inc (THRM) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 10, 2026. The accession number assigned by EDGAR is 0001140361-26-014268.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Gentherm clarifies abstention effects on Proposal 4. Abstentions are not votes; the amendment increases the plan by 1,700,000 shares. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Gentherm Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Gentherm Inc has filed under CIK 903129, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer